透析患者心肌梗死、卒中与肺栓塞死亡率的趋势
该队列研究纳入1998–2015年间来自11个欧洲国家、提供数据给欧洲肾脏协会登记系统的220 467例开始透析的成年患者,随访3年,比较1998–2003、2004–2009、2010–2015三个时期透析患者与一般人群的心肌梗死、卒中、肺栓塞年龄和性别标化死亡比(SMR)。随访期间83 912例死亡,中心肌梗死死亡7662例(9.1%)、卒中死亡5030例(6.0%)、肺栓塞死亡435例(0.5%)。心肌梗死SMR从8.1(95%CI 7.8–8.3)降至6.8(95%CI 6.5–7.1),卒中SMR从7.3(95%CI 7.0–7.6)降至5.8(95%CI 5.5–6.2),肺栓塞SMR从8.7(95%CI 7.6–10.1)降至5.5(95%CI 4.5–6.6)。作者结论认为透析患者上述三种疾病的死亡率下降幅度大于一般人群。
要点
- 2010–2015年透析患者心肌梗死SMR为6.8(95%CI 6.5–7.1),较1998–2003年的8.1(95%CI 7.8–8.3)下降但未达一般人群水平。
- 卒中SMR从1998–2003年的7.3(95%CI 7.0–7.6)降至2010–2015年的5.8(95%CI 5.5–6.2)。
- 肺栓塞SMR从1998–2003年的8.7(95%CI 7.6–10.1)降至2010–2015年的5.5(95%CI 4.5–6.6)。
- 220 467例透析患者随访3年共83 912例死亡,其中心肌梗死占9.1%、卒中占6.0%、肺栓塞占0.5%。
适用人群与场景
- 1998–2015年间开始透析的成年患者,来自11个欧洲国家、提供数据给欧洲肾脏协会登记系统,随访3年。
研究设计与关键结果
- 队列研究纳入220 467例透析患者,中位年龄68.2岁(IQR 56.5–76.4),女性82 068例(37.2%)。
- 随访期间83 912例死亡,其中心肌梗死死亡7662例(9.1%)、卒中死亡5030例(6.0%)、肺栓塞死亡435例(0.5%)。
- 心肌梗死SMR从1998–2003年的8.1(95%CI 7.8–8.3)降至2010–2015年的6.8(95%CI 6.5–7.1)。
- 卒中SMR从1998–2003年的7.3(95%CI 7.0–7.6)降至2010–2015年的5.8(95%CI 5.5–6.2)。
- 肺栓塞SMR从1998–2003年的8.7(95%CI 7.6–10.1)降至2010–2015年的5.5(95%CI 4.5–6.6)。
证据类型、等级与局限
- 证据类型:队列研究(欧洲肾脏协会登记系统数据)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,透析患者心肌梗死、卒中、肺栓塞的死亡率随时间下降幅度大于一般人群;原文未据此给出具体推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: During the past decades, improvements in the prevention and management of myocardial infarction, stroke, and pulmonary embolism have led to a decline in cardiovascular mortality in the general population. However, it is unknown whether patients receiving dialysis have also benefited from these improvements.
OBJECTIVE: To assess the mortality rates for myocardial infarction, stroke, and pulmonary embolism in a large cohort of European patients receiving dialysis compared with the general population.
DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, adult patients who started dialysis between 1998 and 2015 from 11 European countries providing data to the European Renal Association Registry were and followed up for 3 years. Data were analyzed from September 2020 to February 2022.
EXPOSURES: Start of dialysis.
MAIN OUTCOMES AND MEASURES: The age- and sex-standardized mortality rate ratios (SMRs) with 95% CIs were calculated by dividing the mortality rates in patients receiving dialysis by the mortality rates in the general population for 3 equal periods (1998-2003, 2004-2009, and 2010-2015).
RESULTS: In total, 220 467 patients receiving dialysis were included in the study. Their median (IQR) age was 68.2 (56.5-76.4) years, and 82 068 patients (37.2%) were female. During follow-up, 83 912 patients died, of whom 7662 (9.1%) died because of myocardial infarction, 5030 (6.0%) died because of stroke, and 435 (0.5%) died because of pulmonary embolism. Between the periods 1998 to 2003 and 2010 to 2015, the SMR of myocardial infarction decreased from 8.1 (95% CI, 7.8-8.3) to 6.8 (95% CI, 6.5-7.1), the SMR of stroke decreased from 7.3 (95% CI, 7.0-7.6) to 5.8 (95% CI, 5.5-6.2), and the SMR of pulmonary embolism decreased from 8.7 (95% CI, 7.6-10.1) to 5.5 (95% CI, 4.5-6.6).
CONCLUSIONS AND RELEVANCE: In this cohort study of patients receiving dialysis, mortality rates for myocardial infarction, stroke, and pulmonary embolism decreased more over time than in the general population.
参考来源
- Ocak G, Boenink R, Noordzij M, et al. Trends in Mortality Due to Myocardial Infarction, Stroke, and Pulmonary Embolism in Patients Receiving Dialysis. JAMA Netw Open. 2022. PMID: 35435972. doi:10.1001/jamanetworkopen.2022.7624
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。